Search
for
Sort by
Research 271–300 of 1000+
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- The JAK/STAT signaling pathway: from bench to clinic
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Current Treatments for Alopecia Areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Alopecia universalis successfully treated with tofacitinib
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Cholesterol promotes hair growth through activating sympathetic nerves and enhancing the proliferation of hair follicle stem cells
- Baricitinib as a treatment for myasthenia gravis: A case report
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Advances in the mechanism and new therapies of alopecia areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- mTOR signaling in hair follicle and hair diseases: recent progress
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Sorafenib-Associated Facial Acneiform Eruption
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Non-Scarring Alopecia in Females: A Comprehensive Review